Home / Inspections / 1003801

FDA Inspection 1003801 — Actavis Elizabeth LLC

Actavis Elizabeth LLC — FEI 2211563

The FDA completed an inspection of Actavis Elizabeth LLC on February 15, 2017 in Elizabeth, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 15, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Elizabeth, NJ (United States)

Facility

Other inspections at this facility

  • 1215838 (NAI Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041770 (NAI Mon Feb 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 994679 (NAI Mon Dec 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 939866 (VAI Thu Aug 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 908911 (NAI Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources